Letter to HHS and Department of Defense Urging Investigation Into Procedures Leading to Blood Platelet Transfusion Deaths October 25, 2011
Comments regarding the Institute of Medicine’s Report, Medical Devices and the Public’s Health: The FDA 510(k) Clearance Process
Comments to CMS Regarding End-Stage Renal Disease (ESRD) Quality Incentive Program (QIP) for Payment Years (PY) 2013 and 2014 August 1, 2011
Letter Requesting Extension of Advance Notice of Proposed Rulemaking (ANPRM) – Human Subjects July 26, 2011
Letter to HHS Regarding OHRP Failure to Investigate Unethical Placebo-Controlled Trials of Indacaterol Maleate (Arcapta Neohaler) April 28, 2011